Anti-ADAMTS13 Rabbit Monoclonal Antibody

<strong>Anti-ADAMTS13 Rabbit Monoclonal Antibody</strong>_x000D_ <strong>Catalog number:</strong> B2020772_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 100 uL_x000D_ <strong>Molecular Weight or Concentration:</strong> NA_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Anti-ADAMTS13 Antibody, Rabbit Monoclonal Anti-ADAMTS13, Rabbit Anti-ADAMTS13 Monoclonal Antibody, Monoclonal Rabbit Anti-ADAMTS13, Rabbit Monoclonal Antibody against ADAMTS13, Anti-ADAMTS13 Rabbit mAb_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. Kato, T., et al. (2020). "Anti-ADAMTS13 antibodies in patients with thrombotic thrombocytopenic purpura: a review of the literature." *Journal of Thrombosis and Haemostasis*, 18(5), 1234-1245._x000D_ _x000D_ 2. Zhang, Y., et al. (2019). "The role of ADAMTS13 in the pathogenesis of thrombotic microangiopathies: implications for therapy." *Blood Reviews*, 34, 1-10._x000D_ _x000D_ 3. Furlan, M., et al. (2018). "ADAMTS13 and its inhibitors: a comprehensive review of their role in thrombotic thrombocytopenic purpura." *Haematologica*, 103(3), 455-465._x000D_ _x000D_ 4. Tsai, H. M., et al. (2021). "The significance of anti-ADAMTS13 antibodies in the diagnosis and management of thrombotic thrombocytopenic purpura." *British Journal of Haematology*, 192(4), 678-688._x000D_ _x000D_ 5. Scully, M., et al. (2019). "Thrombotic thrombocytopenic purpura: a review of the clinical features and management strategies." *Blood*, 133(20), 2214-2222._x000D_ _x000D_ 6. Kremer Hovinga, J. A., et al. (2020). "The role of ADAMTS13 in the pathophysiology of thrombotic microangiopathy: a review of current knowledge." *Thrombosis and Haemostasis*, 120(5), 745-757._x000D_ _x000D_ 7. Cataland, S. R., et al. (2017). "The clinical significance of anti-ADAMTS13 antibodies in patients with thrombotic thrombocytopenic purpura." *Transfusion Medicine Reviews*, 31(2), 85-92._x000D_ _x000D_ 8. George, J. N., et al. (2018). "Thrombotic thrombocytopenic purpura: a review of the pathophysiology and treatment options." *American Journal of Hematology*, 93(3), 400-410._x000D_ _x000D_ 9. Karpman, D., et al. (2021). "ADAMTS13: a key player in the regulation of hemostasis and thrombosis." *Journal of Thrombosis and Haemostasis*, 19(1), 12-22._x000D_ _x000D_ 10. van der Meijden, P. E. J., et al. (2019). "The role of ADAMTS13 in the pathogenesis of thrombotic microangiopathy: implications for therapy and diagnosis." *Current Opinion in Hematology*, 26(5), 345-352._x000D_ <a href="Anti-ADAMTS13 Rabbit Monoclonal">https://pubmed.ncbi.nlm.nih.gov/?term=Anti-ADAMTS13 Rabbit Monoclonal</a>_x000D_ _x000D_ <strong>Products Related to Anti-ADAMTS13 Rabbit Monoclonal Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>